GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tenon Medical Inc (NAS:TNON) » Definitions » Debt-to-EBITDA

Tenon Medical (Tenon Medical) Debt-to-EBITDA : -0.05 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Tenon Medical Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Tenon Medical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.26 Mil. Tenon Medical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.36 Mil. Tenon Medical's annualized EBITDA for the quarter that ended in Mar. 2024 was $-13.53 Mil. Tenon Medical's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was -0.05.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Tenon Medical's Debt-to-EBITDA or its related term are showing as below:

TNON' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -2.3   Med: -0.6   Max: -0.05
Current: -0.05

During the past 4 years, the highest Debt-to-EBITDA Ratio of Tenon Medical was -0.05. The lowest was -2.30. And the median was -0.60.

TNON's Debt-to-EBITDA is ranked worse than
100% of 439 companies
in the Medical Devices & Instruments industry
Industry Median: 1.26 vs TNON: -0.05

Tenon Medical Debt-to-EBITDA Historical Data

The historical data trend for Tenon Medical's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tenon Medical Debt-to-EBITDA Chart

Tenon Medical Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
-1.07 -2.30 -0.05 -0.12

Tenon Medical Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.05 -0.05 -0.06 -0.16 -0.05

Competitive Comparison of Tenon Medical's Debt-to-EBITDA

For the Medical Devices subindustry, Tenon Medical's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tenon Medical's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tenon Medical's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Tenon Medical's Debt-to-EBITDA falls into.



Tenon Medical Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Tenon Medical's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1.429 + 0.428) / -15.134
=-0.12

Tenon Medical's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.263 + 0.36) / -13.528
=-0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.


Tenon Medical  (NAS:TNON) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Tenon Medical Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Tenon Medical's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Tenon Medical (Tenon Medical) Business Description

Traded in Other Exchanges
N/A
Address
104 Cooper Court, Los Gatos, CA, USA, 95032
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
Executives
Van Dick Steven M officer: Chief Financial Officer HANSEN MEDICAL, INC., 380 N BERNARDO AVENUE, MOUNTAIN VIEW CA 94043
Richard Ginn director, officer: Chief Technology Officer 104 COOPER COURT, LOS GATOS CA 95032
Steven M Foster director, officer: CEO and President 104 COOPER COURT, LOS GATOS CA 95032
Stephen Hochschuler director C/O TENON MEDICAL, INC., 104 COOPER COURT, LOS GATOS CA 95032
Frank M Fischer director 9701 JERONIMO, IRVINE CA 92618
Richard M Ferrari director 2118 WALSH AVENUE, SUITE 210, SANTA CLARA CA 95050
Ivan Howard director 104 COOPER COURT, LOS GATOS CA 95032
Robert K Weigle director 104 COOPER COURT, LOS GATOS CA 95032
Ventures Ag Zuhlke 10 percent owner ZURCHERSTRASSE 39J, SCHLIEREN V8 8952